Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Healthtrust
UBS
Mallinckrodt
Teva
Express Scripts
Cerilliant
McKesson
McKinsey
Julphar

Generated: February 21, 2018

DrugPatentWatch Database Preview

Nexgen Pharma Inc Company Profile

« Back to Dashboard

What is the competitive landscape for NEXGEN PHARMA INC, and what generic and branded alternatives to NEXGEN PHARMA INC drugs are available?

NEXGEN PHARMA INC has fifteen approved drugs.



Summary for Nexgen Pharma Inc
US Patents:0
Tradenames:14
Ingredients:14
NDAs:15

Drugs and US Patents for Nexgen Pharma Inc

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Nexgen Pharma Inc DIPHENHYDRAMINE HYDROCHLORIDE diphenhydramine hydrochloride CAPSULE;ORAL 083634-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc SODIUM PENTOBARBITAL pentobarbital sodium TABLET;ORAL 084238-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc BUTALBITAL, ASPIRIN, CAFFEINE, AND CODEINE PHOSPHATE aspirin; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 075231-001 Nov 30, 2001 AB RX No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc POLYETHYLENE GLYCOL 3350 polyethylene glycol 3350 FOR SOLUTION;ORAL 077706-001 Sep 27, 2006 AA RX No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc MECLIZINE HYDROCHLORIDE meclizine hydrochloride TABLET, CHEWABLE;ORAL 086392-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE acetaminophen; butalbital; caffeine; codeine phosphate CAPSULE;ORAL 076560-001 Jun 10, 2004 AB RX No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc PROPOXYPHENE HYDROCHLORIDE propoxyphene hydrochloride CAPSULE;ORAL 083185-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc FOLIC ACID folic acid TABLET;ORAL 084915-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc DIMENHYDRINATE dimenhydrinate TABLET;ORAL 085985-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Nexgen Pharma Inc MEPROBAMATE meprobamate TABLET;ORAL 084589-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Chinese Patent Office
McKinsey
Healthtrust
Baxter
Accenture
Johnson and Johnson
Cipla
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot